Pneumococcal vaccine conjugate 10-valent - Panacea Biotech
Alternative Names: 10-Valent pneumococcal polysaccharide conjugate vaccine - Panacea Biotech; Nucovac; Pneumococcal 10-valent conjugate vaccine (adsorbed) - Panacea BiotechLatest Information Update: 28 Apr 2018
At a glance
- Originator Panacea Biotec
- Class Conjugate vaccines; Pneumococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I/II Pneumococcal infections
Most Recent Events
- 28 Apr 2018 No recent reports of development identified for phase-I development in Pneumococcal-infections(In infants, Prevention) in India (IM, Injection)
- 20 Apr 2016 Phase-I/II development for Pneumococcal infections (In adults, Prevention) is ongoing in India
- 01 Jun 2013 Phase-I/II clinical trials in Pneumococcal infections (prevention in volunteers) in India (IM)